Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchipret and Sinupret for acceleration of mucociliary clearance
2012-004864-24Phase 2Completed
- Sponsor
- Bionorica
- Start
- Jun 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bronchipret and Sambucus nigra flower in rhinosinusitis and airway morbidity (4 arms), sponsored by Bionorica. Primary endpoint: Primary: Change in time to perception of sweetness after 7 days of treatment. Started Jun 2013; status: completed.
02
Drugs
BronchipretSambucus nigra flower
03
Conditions
rhinosinusitisairway morbidity
Beyond the preview
Go deeper on 2012-004864-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004864-24.